Upper gastrointestinal malignancies in 2017: current perspectives and future approaches

von Solomon, Benjamin L, Garrido-Laguna, Ignacio
Veröffentlicht in Future Oncol (2018)

Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer

von Patel, Shiven B, Gill, David, Garrido-Laguna, Ignacio
Veröffentlicht in Onco Targets Ther (2015)

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

von Au, Trang H., Wang, Kai, Stenehjem, David, Garrido-Laguna, Ignacio
Veröffentlicht in J Gastrointest Oncol (2017)

Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction

von Florou, Vaia, Puri, Sonam, Garrido-Laguna, Ignacio, Wilky, Breelyn A.
Veröffentlicht in Ann Transl Med (2021)

Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle

von Gajiwala, Snehal, Torgeson, Anna, Garrido-Laguna, Ignacio, Kinsey, Conan, Lloyd, Shane
Veröffentlicht in J Gastrointest Oncol (2018)

Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line c...

von Nevala-Plagemann, Christopher, Moser, Justin, Gilcrease, Glynn Weldon, Garrido-Laguna, Ignacio
Veröffentlicht in ESMO Open (2019)

Large database utilization in health outcomes research in pancreatic cancer: an update

von Torgeson, Anna, Tao, Randa, Garrido-Laguna, Ignacio, Willen, Benjamin, Dursteler, Amy, Lloyd, Shane
Veröffentlicht in J Gastrointest Oncol (2018)

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins

von Torgeson, Anna, Garrido-Laguna, Ignacio, Tao, Randa, Cannon, George M, Scaife, Courtney L, Lloyd, Shane
Veröffentlicht in ESMO Open (2018)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer

von Gruhl, Joshua D., Garrido‐Laguna, Ignacio, Francis, Samual R., Affolter, Kajsa, Tao, Randa, Lloyd, Shane
Veröffentlicht in Cancer Med (2020)

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency

von Rengifo-Cam, William, Jasperson, Kory, Garrido-Laguna, Ignacio, Colman, Howard, Scaife, Courtney, Samowitz, Wade, Samadder, N. Jewel
Veröffentlicht in ACG Case Rep J (2017)

Treatment Rechallenge With Checkpoint Inhibition in Patients With Mismatch Repair–Deficient Pancreatic Cancer After Planned Treatment Interruption

von Florou, Vaia, Nevala-Plagemann, Christopher, Barber, Kristin E., Mastroianni, Jenna N., Cavalieri, Courtney C., Garrido-Laguna, Ignacio
Veröffentlicht in JCO Precis Oncol (2020)

N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012

von Garrido-Laguna, Ignacio, Tometich, Danielle, Hu, Nan, Ying, Jian, Geiersbach, Katherine, Whisenant, Jonathan, Wang, Kai, Ross, Jeffrey S., Sharma, Sunil
Veröffentlicht in Oncoscience (2015)

Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy

von Nevala-Plagemann, Christopher, Francis, Samual, Cavalieri, Courtney, Tao, Randa, Whisenant, Jonathan, Glasgow, Robert, Scaife, Courtney, Lloyd, Shane, Garrido-Laguna, Ignacio
Veröffentlicht in ESMO Open (2018)

A framework for genomic biomarker actionability and its use in clinical decision making

von Vidwans, Smruti J., Turski, Michelle L., Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Subbiah, Vivek, Rodon, Jordi, Kurzrock, Razelle
Veröffentlicht in Oncoscience (2014)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

von Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Veröffentlicht 2011

Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Treated in a Phase I Clinic

von Janku, Filip, Tsimberidou, Apostolia M., Wang, Xuemei, Hong, David S., Naing, Aung, Gong, Jing, Garrido-Laguna, Ignacio, Parsons, Henrique A., Zinner, Ralph G., Kurzrock, Razelle
Veröffentlicht 2011

Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer

von Vaishnavi, Aria, Scherzer, Michael T., Kinsey, Conan G., Parkman, Gennie L., Truong, Amanda, Ghazi, Phaedra, Schuman, Sophia, Battistone, Benjamin, Garrido-Laguna, Ignacio, McMahon, Martin
Veröffentlicht in Cell Rep (2020)

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

von Garrido-Laguna, Ignacio, Hong, David S., Janku, Filip, Nguyen, Ly M., Falchook, Gerald S., Fu, Siqing, Wheler, Jenifer J., Luthra, Rajyalakshmi, Naing, Aung, Wang, Xuemei, Kurzrock, Razelle
Veröffentlicht 2012

A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer

von Hidalgo, Manuel, Bruckheimer, Elizabeth, Rajeshkumar, N.V., Garrido-Laguna, Ignacio, De Oliveira, Elizabeth, Rubio-Viqueira, Belen, Strawn, Steven, Wick, Michael J., Martell, James, Sidransky, David
Veröffentlicht in Mol Cancer Ther (2011)

The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA

von Nix, David A., Hellwig, Sabine, Conley, Christopher, Thomas, Alun, Fuertes, Carrie L., Hamil, Cindy L., Bhetariya, Preetida J., Garrido-Laguna, Ignacio, Marth, Gabor T., Bronner, Mary P., Underhill, Hunter R.
Veröffentlicht in PLoS One (2020)